Shetzline SE - Search Results

1

Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias.

Shetzline SE, Rallapalli R, Dowd KJ, Zou S, Nakata Y, Swider CR, Kalota A, Choi JK, Gewirtz AM. Shetzline SE, et al. Blood. 2004 Sep 15;104(6):1833-40. doi: 10.1182/blood-2003-10-3577. Epub 2004 Jun 8. Blood. 2004. PMID: 15187020 Free article.

2

c-Myb contributes to G2/M cell cycle transition in human hematopoietic cells by direct regulation of cyclin B1 expression.

Nakata Y, Shetzline S, Sakashita C, Kalota A, Rallapalli R, Rudnick SI, Zhang Y, Emerson SG, Gewirtz AM. Nakata Y, et al. Mol Cell Biol. 2007 Mar;27(6):2048-58. doi: 10.1128/MCB.01100-06. Epub 2007 Jan 22. Mol Cell Biol. 2007. PMID: 17242210 Free PMC article.

3

The c-Myb target gene neuromedin U functions as a novel cofactor during the early stages of erythropoiesis.

Gambone JE, Dusaban SS, Loperena R, Nakata Y, Shetzline SE. Gambone JE, et al. Among authors: shetzline se. Blood. 2011 May 26;117(21):5733-43. doi: 10.1182/blood-2009-09-242131. Epub 2011 Mar 4. Blood. 2011. PMID: 21378276 Free PMC article.

4

Nucleic acid modulation of gene expression: approaches for nucleic acid therapeutics against cancer.

Nakata Y, Kim TK, Shetzline S, Gewirtz AM. Nakata Y, et al. Crit Rev Eukaryot Gene Expr. 2005;15(2):163-82. doi: 10.1615/critreveukaryotgeneexpr.v15.i2.50. Crit Rev Eukaryot Gene Expr. 2005. PMID: 16022634 Review.

5

c-Myb and GATA-3 cooperatively regulate IL-13 expression via conserved GATA-3 response element and recruit mixed lineage leukemia (MLL) for histone modification of the IL-13 locus.

Kozuka T, Sugita M, Shetzline S, Gewirtz AM, Nakata Y. Kozuka T, et al. J Immunol. 2011 Dec 1;187(11):5974-82. doi: 10.4049/jimmunol.1100550. Epub 2011 Oct 28. J Immunol. 2011. PMID: 22039304 Free PMC article.

6

Progress in the development of nucleic acid therapeutics for cancer.

Kalota A, Shetzline SE, Gewirtz AM. Kalota A, et al. Among authors: shetzline se. Cancer Biol Ther. 2004 Jan;3(1):4-12. doi: 10.4161/cbt.3.1.517. Epub 2004 Jan 18. Cancer Biol Ther. 2004. PMID: 14726654 Free article. Review.

7

Characterization of a 2',5'-oligoadenylate (2-5A)-dependent 37-kDa RNase L: azido photoaffinity labeling and 2-5A-dependent activation.

Shetzline SE, Suhadolnik RJ. Shetzline SE, et al. J Biol Chem. 2001 Jun 29;276(26):23707-11. doi: 10.1074/jbc.M101243200. Epub 2001 Apr 25. J Biol Chem. 2001. PMID: 11323422 Free article.

8

Structural and functional features of the 37-kDa 2-5A-dependent RNase L in chronic fatigue syndrome.

Shetzline SE, Martinand-Mari C, Reichenbach NL, Buletic Z, Lebleu B, Pfleiderer W, Charubala R, De Meirleir K, De Becker P, Peterson DL, Herst CV, Englebienne P, Suhadolnik RJ. Shetzline SE, et al. J Interferon Cytokine Res. 2002 Apr;22(4):443-56. doi: 10.1089/10799900252952235. J Interferon Cytokine Res. 2002. PMID: 12034027

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters